MCTA — Charming Medical Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Charming Medical, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -0.336 | 0.822 | 1.2 | -0.023 |
| Depreciation | ||||
| Deferred Taxes | ||||
| Non-Cash Items | 0.061 | -0.037 | -0.011 | -0.058 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 2.58 | -0.943 | -1.16 | -1.42 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Other Assets | ||||
| Change in Payable / Accrued Expenses | ||||
| Change in Taxes Payable | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | 2.43 | 0.295 | 0.426 | -1.22 |
| Capital Expenditures | -0.606 | -0.211 | -0.288 | -0.34 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | — | — | -1.94 | 0.161 |
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Cash from Investing Activities | -0.606 | -0.211 | -2.23 | -0.179 |
| Financing Cash Flow Items | -1.25 | 0.216 | 0.472 | -0.999 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -1.43 | 0.1 | 0.521 | 5.29 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0.403 | 0.174 | -1.29 | 3.88 |